Cree (CREE) price target and estimates were raised at Sterne Agee. Estimates were increased through 2014. The exclusive deal with Home Depot (HD) to sell its LED light bulbs and gross margin tailwinds will benefit the company, Sterne Agee said. Price target is now $64.
Cree price target and estimates were raised at UBS. Estimates were increased through 2014. The deal with Home Depot and LED bulb pricing will drive growth, UBS said. Price target is now $51.
Darden (DRI) estimates, price target were reduced at Credit Suisse. Estimates were cut through 2015. Olive Garden continues to face challenges, Credit Suisse said. Neutral rating and new $45 price target.
Gilead Sciences (GILD) price target was raised at Lazard Capital Markets to $58. Visit with specialist highlights significant HCV opportunity, Lazard Capital Markets said.News Corp. (NWSA) price target was raised at Lazard Capital Markets to $35. Fox Sports 1 could be a 5% EPS lift, Lazard Capital Markets said. Buy rating. VeriFone (PAY) price target and estimates were cut at UBS. Estimates were cut through 2014 based on management's updated guidance. The company needs to recapture share and revitalize its underperforming products/markets, UBS said. Price target was reduced to $25. Pinnacle West Capital (PNW) price target and estimates were raised at UBS. 2013 earnings estimates were increased slightly, and 2015 estimates were introduced after meeting with management, UBS said. The new price target is $59 and is based on the new 2015 estimates, UBS said. Qualcomm (QCOM) was cut from the Conviction Buy List at Goldman Sachs. $80 price target. Chipset market share will likely peak in 2013, Goldman said. Sally Beauty (SBH) price target and estimates were raised at Sterne Agee. Estimates through 2014 were increased. The new $700 million share repurchase program presents material EPS accretion potential, Sterne Agee said. Price target is now $34. Western Refining (WNR) estimates were updated and its price target was raised at UBS. Earnings were moved from 2013 into 2014 after the company announced it is pursuing the formation of an MLP, UBS said. Price target was increased to $39. Xilinx (XLNX) price target and estimates were raised at UBS. Estimates through 2014 were increased. The company's ability to sustain 28nm market share leadership gives credence to new product execution, UBS said. Price target was increased to $37. >To submit a news tip, email: firstname.lastname@example.org.
Twitter and become a fan on Facebook.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts